78
57
Growth Score 78 in past quarter
-3 pts
Heat Score 57 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
237399
Corium is a commercial-stage biopharmaceutical company that treats conditions of the central nervous system.
- Gary W. Cleary: Co-Founder, President and Co-Chief Technology Officer
- Todd Smith: Chief Executive Officer
About the Company
Corium offers the development and commercialization of central nervous system healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.